AI. WITHOUT METHOD. WITHOUT EFFECT

Welcome to the Companion Universe.

We're pleased you're here.

Your methodical AI companion for when gut instinct becomes too expensive.

The best partner in the decisive moment.

A negotiation where a great deal is at stake. A conversation that has long been avoided. A transformation that has stalled. This is precisely where the Companion supports you as a methodical partner — one who understands the context behind your situation, recognises what is at stake, and guides you through the moment that truly matters.

The right methodology in the given context.

Every situation brings its own complexity. Knowledge must be gathered, validated, and made available at the right moment. Conversations need to be prepared, conducted with intention, and reflected upon afterwards. The Companion combines proven methods with your specific context so that you can act with confidence, structure, and impact at every stage.

Which topics challenge you the most?

Negotiations where much is at stake. Transformations that create friction. Conversations that require tact and sensitivity. Contracts that need careful evaluation. Change processes that must bring people along. And in each of these moments lies the same opportunity: not to prepare AI capability in advance, but to develop it in the very moment it is needed.

Methodical and competent in context.

Every decision deserves a sound foundation. The Companion brings proven frameworks into your specific situation applied with precision, not presented generically. The result is not abstract advice, but methodological confidence in action: exactly where you need it, and exactly when it matters.

The Companion is an AI-powered companion for your critical processes.

Not a know-it-all, but a sparring partner.

It connects your specific data and situations with proven methodological expertise while always remaining on equal footing. Harvard when it comes to negotiations. Kotter and Lewin when change must be managed, along with other frameworks that are not chosen by chance but because they work.

Structured strategy development with scenario simulation, option generation, and methodological completeness checks — complemented by critical reflection questions and best- and worst-case scenario runs.

Situation-based guidance with quick checks during breaks, well-founded courses of action based on the current status, and adjustments when unexpected developments arise.

Systematic analysis of outcomes and improvement potential, pattern recognition across multiple iterations, and documented capability development with concrete recommendations for the next cycle.

The Companion platform is deliberately designed as a secure learning environment. While working on real processes, you simultaneously build practical AI capability — not through abstract training, but through your daily work.

Real decisions remain with you. The Companion supports, challenges, and presents options but you retain control. A balance between human expertise and digital support.

AI capability through practice rather than theory.
Build AI capability where it is truly needed: within real working processes. Companions foster AI acceptance through practical, hands-on experience.
Risk minimisation instead of gut feeling.
Avoid costly misjudgements, failed negotiations, and entrenched conflicts through structured preparation and scenario simulation in a secure environment.
Time savings and better preparation.
Reduce your preparation time by up to 60% while improving the quality of your decisions — all while systematically building methodological expertise
Methodologically excellent in a safe environment.
Work on the basis of established, proven methods and frameworks. Test strategies, practise difficult conversations, and simulate resistance before entering the real situation.
Modular and precise — like a puzzle.
Start with one module. If the situation requires it, add more modules. From one module comes a chain. From a chain, a fully supported process.
AI capability through practice rather than theory.
Build AI capability where it is truly needed: within real working processes. Companions foster AI acceptance through practical, hands-on experience.
Risk minimisation instead of gut feeling.
Avoid costly misjudgements, failed negotiations, and entrenched conflicts through structured preparation and scenario simulation in a secure environment.
Time savings and better preparation.
Reduce your preparation time by up to 60% while improving the quality of your decisions — all while systematically building methodological expertise
Methodologically excellent in a safe environment.
Work on the basis of established, proven methods and frameworks. Test strategies, practise difficult conversations, and simulate resistance before entering the real situation.
Modular and precise — like a puzzle.
Starten Sie mit einem Baustein,. Wenn die Situation es erfordert, ergänzen Sie um weitere Bausteine. Aus dem Baustein wird eine Kette. Aus einer Kette ein vollständig begleiteter Prozess.
KI-Kompetenz durch Praxis
Risiko Minimierung
Bessere Vorbereitung
Methodisch exzellent
Modular wie ein Puzzle

Strategic Sales.

From tender submission to signed contract.

A B2B software company receives an RFP for a €480,000 deal — with eight weeks to respond and a buying centre of seven stakeholders. The last three comparable deals were lost, each time with the same feedback: “Your expertise was excellent, but…”

Strategic Decision Companion: Structure the go/no-go decision, assess the probability of success, and evaluate portfolio allocation.

Stakeholder Management Companion: Identify all decision-makers, create a power–interest grid, and activate a champion.

Harvard Negotiation Companion: Develop the BATNA, analyse the client’s interests, and identify critical negotiation moments.

A “hidden blocker” was identified early and deliberately engaged. The price negotiation concluded with an 8% discount instead of the usual 15–20% — because the BATNA was clearly defined.

“For the first time, I felt that I was truly steering the deal rather than merely reacting.”

Leadership and conversations

From a critical employee conversation to a constructive turning point.

A team leader must speak with her senior controller (eight years with the company): missed deadlines, errors in reports, and complaints from the team. HR is pushing for a documented conversation. The dilemma: too hard he resigns; too soft nothing changes.

DISC Companion – Analyse the behavioural profile: High C — requires structure, facts, and time to process. Avoid putting them under pressure.

Difficult Conversations Companion – Develop a nonviolent communication structure, prepare SBI examples, simulate emotional reactions, and clarify legal boundaries.

Delegation Companion – Define measures and follow-up meetings, and prepare legally compliant documentation.

The real reason emerged: caring for his mother with dementia — something he had concealed out of shame. The nonviolent communication structure created the space for this to surface. After eight weeks: performance stabilised and trust had grown.

“Without the preparation, I would never have created the space for him to open up.”

Change Management

From a blocked implementation to an accepted change.

A manufacturing company (450 employees) invests €1.2 million in an AI planning tool — after six weeks of the pilot phase: 23% adoption. Key users are blocking progress, and training sessions are being avoided. Three failed initiatives in the past five years have created deep mistrust.

Reifegradanalyse Companion: Spannungsfeld Dimensionen analysieren, Strukturelle und Kulturelle Reife bewerten.

Lewin Transformation Companion: Develop a force field analysis, define action areas and structural measures, and create visions, missions, quick wins, and prototypes.

Kotter Change Companion: Create a sense of urgency, build a leadership coalition, identify resistance, and implement the change process.

he most sceptical shift supervisor became an “AI ambassador” — his first suggestion was implemented within 48 hours. Go-live reached 78% adoption (benchmark: 45%), with sustained usage of 84% after six months.

“AI projects are not IT projects — they are change projects.”

Strategic Sales.

From tender submission to signed contract.

A B2B software company receives an RFP for a €480,000 deal — with eight weeks to respond and a buying centre of seven stakeholders. The last three comparable deals were lost, each time with the same feedback: “Your expertise was excellent, but…”

Strategic Decision Companion: Structure the go/no-go decision, assess the probability of success, and evaluate portfolio allocation.

Stakeholder Management Companion: Identify all decision-makers, create a power–interest grid, and activate a champion.

Harvard Negotiation Companion: Develop the BATNA, analyse the client’s interests, and identify critical negotiation moments.

A “hidden blocker” was identified early and deliberately engaged. The price negotiation concluded with an 8% discount instead of the usual 15–20% — because the BATNA was clearly defined.

“For the first time, I felt that I was truly steering the deal rather than merely reacting.”

Führung und Gespräche

From a critical employee conversation to a constructive turning point.

A team leader must speak with her senior controller (eight years with the company): missed deadlines, errors in reports, and complaints from the team. HR is pushing for a documented conversation. The dilemma: too hard he resigns; too soft nothing changes.

DISC Companion – Analyse the behavioural profile: High C — requires structure, facts, and time to process. Avoid putting them under pressure.

Difficult Conversations Companion – Develop a nonviolent communication structure, prepare SBI examples, simulate emotional reactions, and clarify legal boundaries.

Delegation Companion – Define measures and follow-up meetings, and prepare legally compliant documentation.

The real reason emerged: caring for his mother with dementia — something he had concealed out of shame. The nonviolent communication structure created the space for this to surface. After eight weeks: performance stabilised and trust had grown.

“Without the preparation, I would never have created the space for him to open up.”

Change Management

From a blocked implementation to an accepted change.

A manufacturing company (450 employees) invests €1.2 million in an AI planning tool — after six weeks of the pilot phase: 23% adoption. Key users are blocking progress, and training sessions are being avoided. Three failed initiatives in the past five years have created deep mistrust.

Reifegradanalyse Companion: Spannungsfeld Dimensionen analysieren, Strukturelle und Kulturelle Reife bewerten.

Lewin Transformation Companion: Develop a force field analysis, define action areas and structural measures, and create visions, missions, quick wins, and prototypes.

Kotter Change Companion: Create a sense of urgency, build a leadership coalition, identify resistance, and implement the change process.

he most sceptical shift supervisor became an “AI ambassador” — his first suggestion was implemented within 48 hours. Go-live reached 78% adoption (benchmark: 45%), with sustained usage of 84% after six months.

“AI projects are not IT projects — they are change projects.”

Customer Service

From escalation to a strengthened partnership in 48 hours

The most important customer (€850,000 ARR) threatens to terminate the contract after two weeks of system instability. The CTO sends an angry email — CC to the CEO — with a video call scheduled for tomorrow. The CSM is expected to lead the conversation, acting as a lightning rod for problems he did not cause.

DISC Model Companion: Analyse the CTO’s personality profile — high D indicator: direct, solution-oriented, no excuses.

Difficult Conversations Companion: Develop a Nonviolent Communication structure, simulate emotional reactions, and define the compensation framework.

Stakeholder Management Companion: Identify the CFO as the actual decision-maker, activate an internal advocate, and clarify the escalation path.

The conversation remained constructive rather than escalating. Clear measures were agreed, the contract continues and the relationship was even strengthened.

“This is what I call a true partnership.”

Legal / Controlling

From contract template to risk-assessed approval.

An IT services provider is negotiating a €320,000 deal. The draft contract arrives on Friday at 4 p.m., with the signature expected on Monday. The last similar contract resulted in a liability case of €180,000. Legal has become more cautious, while sales argues: “You slow down every deal.”

Contract Review Companion – Compare terms and conditions, identify critical clauses, and prioritise them: critical vs. negotiable vs. acceptable.

Strategic Decision Companion – Create a risk matrix, quantify financial implications, and classify red lines.

Stakeholder Management Companion – Orchestrate the approval process and resolve the Sales–Legal conflict on the basis of shared facts.

The review was completed in four hours instead of two days. Three red lines were identified, and the deal was concluded with adjusted terms and clear risk protection.

“For the first time, Sales and Legal had the same factual basis.”

OOS-QS in Pharma

From a critical OOS finding to complete documentation

A pharmaceutical company faces the release decision for a batch of Lisinopril 10 mg -500,000 tablets with a value in the seven-figure range. The HPLC content measures 94.2% / 0.8% below the specification limit. OOS. The analyst suspects a pipetting error, but the investigation report is incomplete: two test points remain open, no Phase I conclusion has been documented, no CAPA has been defined, and two signatures are missing. The 24-hour deadline for Phase I is running. Several documents the certificate of analysis, the OOS report, and the internal guideline must be assessed simultaneously. An error in the documentation would mean batch quarantine, regulatory risk, and significant delay.

Contract Review Companion – Review the certificate of analysis and the OOS report against QRL-OOS-001: evaluate all eight parameters and systematically identify and prioritise critical deficiencies (missing signatures, open test points, missing CAPA).

Strategic Decision Companion – Create a risk matrix, classify the primary suspicion (pipette P-2847) as the highest priority, and run the Phase I decision tree: laboratory error demonstrable yes/no — deriving the permissible next action from the result.

Stakeholder Management Companion – Coordinate the release process: align the analyst, laboratory head Dr Weber, and QA release manager Ms Müller with clear responsibilities and deadlines, and define the escalation path.

Review of three documents in under 20 minutes instead of several hours of manual analysis. All six open actions prioritised and assigned. Phase I decision documented and ready for release — without regulatory risk.

“AI projects are not IT projects — they are change projects.”

Customer Service

From escalation to a strengthened partnership in 48 hours

The most important customer (€850,000 ARR) threatens to terminate the contract after two weeks of system instability. The CTO sends an angry email — CC to the CEO — with a video call scheduled for tomorrow. The CSM is expected to lead the conversation, acting as a lightning rod for problems he did not cause.

DISC Model Companion: Analyse the CTO’s personality profile — high D indicator: direct, solution-oriented, no excuses.

Difficult Conversations Companion: Develop a Nonviolent Communication structure, simulate emotional reactions, and define the compensation framework.

Stakeholder Management Companion: Identify the CFO as the actual decision-maker, activate an internal advocate, and clarify the escalation path.

The conversation remained constructive rather than escalating. Clear measures were agreed, the contract continues and the relationship was even strengthened.

“This is what I call a true partnership.”

Legal / Controlling

From contract template to risk-assessed approval.

An IT services provider is negotiating a €320,000 deal. The draft contract arrives on Friday at 4 p.m., with the signature expected on Monday. The last similar contract resulted in a liability case of €180,000. Legal has become more cautious, while sales argues: “You slow down every deal.”

Contract Review Companion – Compare terms and conditions, identify critical clauses, and prioritise them: critical vs. negotiable vs. acceptable.

Strategic Decision Companion – Create a risk matrix, quantify financial implications, and classify red lines.

Stakeholder Management Companion – Orchestrate the approval process and resolve the Sales–Legal conflict on the basis of shared facts.

The review was completed in four hours instead of two days. Three red lines were identified, and the deal was concluded with adjusted terms and clear risk protection.

“For the first time, Sales and Legal had the same factual basis.”

OOS-QS in Pharma

From a critical OOS finding to complete documentation

A pharmaceutical company faces the release decision for a batch of Lisinopril 10 mg -500,000 tablets with a value in the seven-figure range. The HPLC content measures 94.2% / 0.8% below the specification limit. OOS. The analyst suspects a pipetting error, but the investigation report is incomplete: two test points remain open, no Phase I conclusion has been documented, no CAPA has been defined, and two signatures are missing. The 24-hour deadline for Phase I is running. Several documents the certificate of analysis, the OOS report, and the internal guideline must be assessed simultaneously. An error in the documentation would mean batch quarantine, regulatory risk, and significant delay.

Contract Review Companion – Review the certificate of analysis and the OOS report against QRL-OOS-001: evaluate all eight parameters and systematically identify and prioritise critical deficiencies (missing signatures, open test points, missing CAPA).

Strategic Decision Companion – Create a risk matrix, classify the primary suspicion (pipette P-2847) as the highest priority, and run the Phase I decision tree: laboratory error demonstrable yes/no — deriving the permissible next action from the result.

Stakeholder Management Companion – Coordinate the release process: align the analyst, laboratory head Dr Weber, and QA release manager Ms Müller with clear responsibilities and deadlines, and define the escalation path.

Review of three documents in under 20 minutes instead of several hours of manual analysis. All six open actions prioritised and assigned. Phase I decision documented and ready for release — without regulatory risk.

“AI projects are not IT projects — they are change projects.”

Talk to us:

Eliminate risks in decision-making.

Through scenario simulation and structured preparation before the real situation.

Establish AI capability across the entire organisation.

Through every Companion cycle as an experiential, GDPR-compliant learning moment.

Ensure sustainable learning.

Through documented patterns and measurable capability development from cycle to cycle.

Save time and increase quality.

Through AI-supported preparation that saves 20–40 hours per process.

Guarantee methodological excellence.

Through the consistent application of Harvard, Kotter, DISC, and Design Thinking.

Start small — grow flexibly.

Through a single Companion that integrates modularly into the overall process.

Eliminate risks in decision-making.

Through scenario simulation and structured preparation before the real situation.

Establish AI capability across the entire organisation.

Through every Companion cycle as an experiential, GDPR-compliant learning moment.

Ensure sustainable learning.

Through documented patterns and measurable capability development from cycle to cycle.

Save time and increase quality.

Through AI-supported preparation that saves 20–40 hours per process.

Guarantee methodological excellence.

Through the consistent application of Harvard, Kotter, DISC, and Design Thinking.

Start small — grow flexibly.

Through a single Companion that integrates modularly into the overall process.

en_GBEnglish

Contact

Telefon: (+49) 0 151 2306 5518

Mail: Kontakt@NexQube.com

QA-Assistent | KI Manufaktur – NexQube
QRL-OOS-001
🤖

KI-gestützte OOS-Prüfung in der Pharmaindustrie

Dieses System demonstriert, wie Künstliche Intelligenz pharmazeutische Qualitätsdokumente automatisiert analysiert, bewertet und regulatorisch konforme Prüfberichte erstellt – in Sekunden statt Stunden.

⚗️
Was ist OOS?
Out-of-Specification bedeutet: ein Messergebnis liegt außerhalb der zugelassenen Grenzwerte. Bei Arzneimitteln kann das die Patientensicherheit gefährden.
📋
Das Problem heute
OOS-Prüfungen werden manuell durchgeführt – zeitaufwendig, fehleranfällig und oft inkonsistent. Regulatoren wie FDA und EMA fordern lückenlose Dokumentation.
🚀
Die KI-Lösung
KI liest Dokumente, erkennt Abweichungen, prüft Vollständigkeit und generiert sofort GMP-konforme Prüfberichte gemäß QRL-OOS-001.

⚡ So funktioniert die Demo

1
Dokument wählen
CoA oder OOS-Bericht einreichen
2
Vorschau
Originaldaten werden angezeigt
3
KI analysiert
Automatisierte Prüfung läuft
4
Prüfbericht
GMP-konformer Output in Sekunden
ℹ️ Demo-Hinweis: Diese Simulation verwendet reale Dokumentstrukturen aus der pharmazeutischen Praxis (Lisinopril 10mg, Charge LIS-2024-0847). Die KI-Analyse ist für Präsentationszwecke gestaltet und zeigt das Potenzial eines produktiven Systems.
Powered by NexQube · KI Manufaktur
Dokument zur Prüfung einreichen
Wählen Sie den Dokumenttyp, den Sie zur automatisierten QA-Prüfung einreichen möchten.
📋
Analysenzertifikat
Certificate of Analysis (CoA)
Prüfergebnisse einer Charge mit Spezifikationsvergleich und Konformitätsbewertung.
📄 CoA-2024-00847 💊 Lisinopril 10 mg Tabletten 📦 Charge: LIS-2024-0847
Zur Prüfung einreichen →
⚠️
OOS-Untersuchung
OOS-Untersuchungsbericht
Dokumentation der Phase-I-Laboruntersuchung nach Out-of-Specification-Ergebnis.
📄 OOS-2024-0089 💊 Lisinopril 10 mg Tabletten 🔬 Gehalt: 94,2 % (OOS)
Zur Prüfung einreichen →
📋

Analysenzertifikat CoA-2024-00847

Eingereicht von: Dr. M. Schmidt  ·  Prüfdatum: 28.02.2024  ·  PharmaCorp GmbH

Produkt
Lisinopril 10 mg Tabletten
Chargennummer
LIS-2024-0847
Chargengröße
500.000 Tabletten
Verfallsdatum
02/2026
Freigabestatus
AUSSTEHEND
Artikel-Nr.
4711-LIS-010
PrüfparameterSpezifikationErgebnisStatus
AussehenWeiße bis cremefarbene TablettenEntsprichtKONFORM
Identität (HPLC)Retentionszeit entspricht StandardEntsprichtKONFORM
Identität (IR)Spektrum entspricht ReferenzEntsprichtKONFORM
Gehalt Lisinopril95,0 – 105,0 %94,2 %OOS
Gleichförmigkeit der Massemax. +/- 5%+/- 1,8 %KONFORM
Zerfallmax. 15 Minuten8 minKONFORM
Friabilitätmax. 1,0 %0,3 %KONFORM
Mikrobio. ReinheitTAMC < 1000 KBE/g< 10 KBE/gKONFORM
⚠️

OOS-Untersuchungsbericht OOS-2024-0089

Eingereicht von: Dr. M. Schmidt  ·  OOS-Datum: 28.02.2024  ·  PharmaCorp GmbH

Produkt
Lisinopril 10 mg Tabletten
Chargennummer
LIS-2024-0847
Prüfparameter
Gehalt Lisinopril (HPLC)
OOS-Ergebnis
94,2 % (Spec: 95–105%)
Status
IN BEARBEITUNG
Priorität
Hoch
Prüfpunkt (Phase I)StatusBemerkung
Berechnungen korrekt?✓ JANachrechnung durch Laborleitung bestätigt
Dokumentation vollständig?✓ JALaborjournal S. 47–48 geprüft
Geräte kalibriert?✓ JAHPLC kalibriert (15.02.2024)
Reagenzien in Haltbarkeit?✓ JAAcetonitril, Puffer geprüft
Methode korrekt befolgt?■ OFFEN
Probe korrekt vorbereitet?✓ JAPipettierfehler vermutet (P-2847)
Pipetten-Kalibrierung?■ OFFENKernverdacht – nicht geprüft
KI-Analyse läuft…
Dokument wird verarbeitet
Powered by NexQube · KI Manufaktur
Dok.-Nr.
PRB-CoA-2024-00847
Erstellt am
04.03.2026, 14:33
Erstellt von
QA-Assistent (auto)
📊 Ergebnisübersicht
PrüfparameterSpezifikationErgebnisStatus
AussehenWeiße bis cremefarbene TablettenEntsprichtKONFORM
Identität (HPLC)Retentionszeit entspricht StandardEntsprichtKONFORM
Identität (IR)Spektrum entspricht ReferenzEntsprichtKONFORM
Gehalt Lisinopril95,0 – 105,0 %94,2 %OOS
Gleichförmigkeit der Massemax. +/- 5%+/- 1,8 %KONFORM
Zerfallmax. 15 Minuten8 minKONFORM
Friabilitätmax. 1,0 %0,3 %KONFORM
Mikrobio. ReinheitTAMC < 1000 KBE/g< 10 KBE/gKONFORM

Befund: 7 von 8 Parametern konform | 1 OOS (Gehalt Lisinopril: 94,2 % liegt 0,8 % unter Spezifikationsgrenze von 95,0 %)

🔎 OOS-Details
Parameter:Gehalt Lisinopril (HPLC intern)
Spezifikation:95,0 – 105,0 %
Ergebnis:94,2 %
Abweichung:-0,8 % (unterhalb Untergrenze)

"Die Pipette war möglicherweise nicht korrekt kalibriert. Ich vermute einen Pipettierfehler bei der Probenvorbereitung." — Dr. M. Schmidt

Bewertung: Verdacht ist plausibel, muss jedoch in Phase I dokumentiert nachgewiesen werden.

📋 Erforderliche Maßnahmen gemäß QRL-OOS-001

Sofortmaßnahmen:

  • Charge LIS-2024-0847 vorläufig sperren
    QA
  • OOS-Nummer vergeben und Untersuchung eröffnen
    QA
  • Laborleitung informieren
    Analyst

Phase I – Laboruntersuchung (innerhalb 24 Stunden):

  • Berechnungen nachrechnen
    Laborleitung
  • Dokumentation / Laborjournal prüfen
    Laborleitung
  • HPLC-Kalibrierung verifizieren
    Analyst
  • Reagenzien-Haltbarkeit prüfen
    Analyst
  • Methodendurchführung bestätigen
    Laborleitung
  • Pipetten-Kalibrierprotokoll prüfen (KERNVERDACHT)
    Laborleitung
⚠️ WARNUNG: "Testing into Compliance" ist gemäß Abschnitt 5 der Richtlinie QRL-OOS-001 strengstens untersagt! Ein Retest ist nur bei dokumentiert nachgewiesenem Laborfehler zulässig.
Dok.-Nr.
PRB-2024-0089
Erstellt am
04.03.2026, 14:29
Erstellt von
QA-Assistent (auto)
📋 Vollständigkeitsprüfung gemäß QRL-OOS-001, Abschnitt 6
AbschnittStatusBefund
1. Allgemeine Informationen✓ Vollständig
2. Phase I – Laboruntersuchung■ Unvollständig2 Prüfpunkte offen
3. Beschreibung vermuteter Fehler✓ Dokumentiert
4. Schlussfolgerung Phase I✗ FehltKeine Entscheidung dokumentiert
5. Eingeleitete Maßnahmen✓ Dokumentiert
6. CAPA-Maßnahmen✗ Fehlt"noch nicht definiert"
7. Unterschriften■ Unvollständig2 von 3 fehlen
🔴 Kritische Mängel

Offene Prüfpunkte Phase I:

  • 🟠
    Methode korrekt befolgt? — Status: Offen | Kritikalität: Hoch
  • 🔴
    Pipetten-Kalibrierung? — Status: Offen | Kritikalität: Sehr hoch – betrifft Kernverdacht

Hinweis: Der Analyst vermutet einen Pipettierfehler (Pipette Ser.Nr. P-2847), jedoch wurde das Kalibrierprotokoll nicht geprüft. Ohne dokumentierten Nachweis kann gemäß Abschnitt 2.3 und 5 kein zuweisbarer Fehler festgestellt und kein Retest durchgeführt werden.

Fehlende Unterschriften:

  • 🔴Laborleitung (Dr. K. Weber) – fehlt
  • 🔴QA-Freigabe (Fr. L. Müller) – fehlt
✅ Erforderliche Maßnahmen vor Freigabe
  • 1
    Kalibrierprotokoll Pipette P-2847 prüfen und dokumentieren
    Laborleitung
  • 2
    Prüfpunkt "Methode korrekt befolgt?" abschließen
    Analyst
  • 3
    Schlussfolgerung Phase I dokumentieren (Laborfehler ja/nein)
    Laborleitung
  • 4
    CAPA-Maßnahmen definieren
    QA
  • 5
    Unterschrift Laborleitung einholen
    Dr. K. Weber
  • 6
    Unterschrift QA-Freigabe einholen
    Fr. L. Müller